Jump to content

Latest

This stream auto-updates

  1. Earlier
  2. Schools are trusted institutions in their communities and can play a vital role in promoting COVID-19 vaccination. From setting up a school-located vaccination clinic to engaging with trusted community partners, there are many ways schools can help to increase vaccination uptake among students and the broader community. To support a safe and healthy return to school, the Public Health Communications Collaborative and the COVID Collaborative have created a one-page resource for school administrators, educators, and staff with resources created or curated by the CDC.
  3. FAQs regarding the flu season 2021-2022. The questions and answers include information on the flu vaccine, the viral strains circulating, the flu vaccine coverage, information on seasonal flu in the context of COVID-19, as well as information for healthcare professionals. Resource available in Spanish.
  4. Vaccine adverse event reports are simultaneously a valuable public health resource and potent ingredients for vaccine misinformation. Its role in vaccine misinformation is due in large part to the logical fallacy of "post hoc ergo propter hoc", where an event that preceded another is thought to be the cause of the later event. However, we can avoid falling into the trap of this logical fallacy by using the Bradford-Hill framework when inferring causality between a vaccine and adverse events. Written for a general audience.
  5. This educational figure is part of an article entitled "Human Papillomavirus Is Dangerous—But a Vaccine Can Save You!"
  6. The National Public Health Information Coalition (NPHIC) "Public Health Speaks" is a monthly podcast series on topical public health issues to educate, inform and assist our members, partners and affiliate organizations in understanding and overcoming urgent communication challenges.
  7. In this episode we talk with Monife Stout, Director of the Territorial Immunization Program for the U.S. Virgin Islands Department of Health. We will discuss the important alliance between public health communicators and immunization professionals and ways we can work more effectively together.
  8. IMAC COVID-19 has been contracted by the Ministry of Health to provide education and support to all health professionals and allied workforces across New Zealand during the rollout. They are supporting vaccinators and the healthcare workforce with training and information to administer COVID-19 vaccines in New Zealand. With their team based around the country, they provide on-the-ground support and customized education for engagement in different community settings, in addition to the online learning courses. The course can be adapted and used by other colleagues in other locations.
  9. Wondering how the mRNA vaccines are processed? Check out our newly released animation, “How mRNA Vaccines Work.”
  10. This infographic highlights the importance of getting children caught up on well-child visits and routine childhood vaccinations. The infographic is available to download and print.
  11. The latest on the COVID-19 global situation and monitoring vaccine safety. It is part of a larger pool of resources related to COVID-19 pandemic.
  12. Educational video on thrombosis with thrombocytopenia syndrome following adenoviruses vaccines against COVID-19.
  13. Training module The training module, in the form of presentation slides, provides a structured approach to assist health workers with interpersonal communication during COVID-19 vaccination consultations and is tailored to specific patient positions on vaccination. Participants are guided through 6 learning parts focusing on a combination of theory and practical skill building scenarios. Relevant COVID-19 vaccine and vaccination resources for health workers are provided to support vaccination consultations. This training is primarily for frontline health workers who will be vaccinators. Facilitator’s guide The Facilitator’s guide is designed to accompany the training module, providing detailed explanations and resources for all parts of the training module. A pre and post training self-reflection survey and post-training evaluation tool is also included. The facilitator’s guide is intended for training facilitators or Trainers of Trainers (ToTs) who will be conducting the training at the country level. Job aid The job aid is an interpersonal communication tool designed to support health workers in facilitating structured and collaborative COVID-19 vaccination conversations with patients, aiming to increase vaccine confidence and acceptance. It is intended for use in vaccination consultation settings.
  14. Pregnant women may safely receive inactivated vaccines, such as Tdap and the flu shot. They share everything with their babies. That means when a pregnant woman gets vaccines, she isn’t just protecting herself— she is giving the baby some early protection too.
  15. CDC regularly creates reports about the status of COVID-19 vaccine confidence in the United States, emphasizing major themes that influence vaccine confidence and uptake. The reports include analyses of multiple quantitative and qualitative data sources, ranging from social listening and web metrics to immunization survey data and CDC-INFO inquiries. The reports seek to identify emerging issues of misinformation, disinformation, and places where intervention efforts can positively increase vaccine confidence across the United States.
  16. Are the existing vaccines protective against all the COVID-19 variants of concern? Are the existing vaccines protective against all the COVID-19 variants of concern?
  17. Informations en français sur la sécurité des vaccins (Johnson & Johnson, Pfizer-BioNTech, Moderna) contre COVID-19.
  18. This programme consists of seven knowledge sessions with accompanying assessments. It is recommended that those new to immunisation complete all seven sessions. Those with prior knowledge and experience in immunisation may wish to read through the relevant knowledge sessions for refresher training or undertake the assessment sessions to check on their knowledge. Learners may also wish to only undertake the sessions relevant to their role. On completion of the knowledge sessions and assessments, users can print a certificate as evidence of the sessions undertaken. A period of supervised practice to allow acquisition and observation of clinical skills and application of knowledge to practice for practitioners new to immunisation is also recommended, as is the completion of an immunisation competency checklist.
  19. The National Foundation for Infectious Diseases (NFID) convened a multidisciplinary group of experts at a virtual roundtable in January 2021 to share research, insights, and best practices for improving and harmonizing communication to the public about the evolving COVID-19 pandemic and the importance of following evidence-based public health prevention measures.
  20. Updated resources regarding zoster vaccine for Australian adults: they include fact sheet, FAQs and a screening form for contraindications.
  21. Immunize Canada has assisted with developing the KT tools for the CARD system and the Hospital for SickKids (Toronto, Canada) through their AboutKidsHealth outreach program is also developing new tools for us to disseminate. These tools are for adults, children and healthcare providers ( https://immunize.ca/card-kids-and-adolescents ; https://immunize.ca/fr/systeme-card-pour-les-enfants-et-les-adolescents ; https://immunize.ca/fr/card-pour-les-adultes ; https://immunize.ca/card-adults ; https://immunize.ca/card ) and have been translated into French but CARD can be adapted to different local/cultural contexts and languages.
  22. COVAX, the largest and most complex global distribution of vaccines is under way, protecting the most vulnerable from COVID-19, wherever they are in the world. In order to end the acute phase of the pandemic and protect the world against the spread of new variants, the global roll-out must continue at unprecedented speed. The COVAX AMC has raised US$ 9.6 billion to date. This vital funding will enable COVAX to protect almost 30% of the population in 91 lower-income economies. But the COVAX delivery schedule has been hit hard by supply delays, and faces a supply shortfall of 190 million doses. To change the course of the pandemic, plug this short-term gap and help ensure equitable access to vaccines through COVAX: o Countries that have doses need to share them now – not later, when countries’ demand and ability to absorb doses will be met by hundreds of millions of doses that will be available through COVAX Facility deals. o Manufacturers need to prioritise COVAX. o Multilateral development banks must urgently release the funds to pay for health system preparedness to ensure countries can absorb the doses delivered. We call on the international community to reaffirm its support for the COVAX AMC and act urgently as One World Protected: Committed to Deliver.
  23. This document provides answers to some of the most frequently asked questions around coronavirus and the Covid-19 vaccine for a general public audience. This document will be updated regularly, and changes will be highlighted in yellow. Please look out for further iterations from your regional NHSEI communications team, and if in any doubt please check with them that you are using the latest version. Contents include: Coronavirus, About the Covid-19 vaccine, Covid-19 vaccine – eligibility, Covid-19 vaccine – timing, Covid-19 vaccine safety, Covid-19 vaccine side-effects, Covid-19 vaccine effectiveness, Covid-19 vaccine ingredients, Vaccine hesitancy, Second doses.
  24. A vaccine to prevent COVID-19 is likely to be the most effective way to control the pandemic. Scientists across the world have worked to develop vaccines which have then been rigorously tested for safety and efficacy. Those with a role in delivering/supporting the COVID-19 vaccine programme need to be knowledgeable, confident and competent in order to promote confidence in the vaccination programme and deliver the vaccine safely. The purpose of this pack is to ensure you have all the resources and information you need to hand, acting as a ‘go to guide’ to support you when talking with patients who are eligible for a Covid-19 vaccination but are showing signs of hesitancy. People may be concerned about or refusing the vaccine due to worries, fears, unclear about messages or for many other reasons. It’s important to understand that people will have their point of view and it may take time to talk through their concerns. Using Motivational Interviewing techniques, listening skills and sharing factual information about Covid-19 and the vaccine may help to encourage people and offer reassurance.
  25. The HHS "We Can Do This" campaign is a national initiative working hand in hand with trusted leaders and community organizations to continue to build confidence in COVID-19 vaccines and get more people vaccinated. This campaign offers tailored resources and toolkits for stakeholders to use to provide COVID-19 vaccine information to at-risk populations.
  1. Load more activity
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines